Skip to search form
Skip to main content
>
Semantic Scholar
Semantic Scholar's Logo
Search
Sign In
Create Free Account
You are currently offline. Some features of the site may not work correctly.
SU 10944
Known as:
SU-10944
, SU10944
National Institutes of Health
Create Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Vascular patterning and permeability in prostate cancer models with differing osteogenic properties
H. Dafni
,
A. Burghardt
,
S. Majumdar
,
N. Navone
,
S. Ronen
NMR in biomedicine
2012
Corpus ID: 22392214
Bone metastasis is a major cause of morbidity and mortality in prostate cancer. However, the lack of clinically relevant models…
Expand
2009
2009
Vascular endothelial growth factor upregulates expression of annexin A2 in vitro and in a mouse model of ischemic retinopathy
Shi-hong Zhao
,
L. Huang
,
J. Wu
,
Y. Zhang
,
D. Pan
,
X. Liu
Molecular vision
2009
Corpus ID: 15096038
Purpose Annexin A2 has been shown to play a role in many neovascularization diseases. We investigated the effect of vascular…
Expand
Highly Cited
2006
Highly Cited
2006
Contribution of individual targets to the antitumor efficacy of the multitargeted receptor tyrosine kinase inhibitor SU11248
O. Potapova
,
A. Laird
,
+5 authors
D. B. Mendel
Molecular Cancer Therapeutics
2006
Corpus ID: 24226929
Recent achievements in the development of multitargeted molecular inhibitors necessitate a better understanding of the…
Expand
2003
2003
A Selective and Oral Small Molecule Inhibitor of Vascular Epithelial Growth Factor Receptor (VEGFR)-2 and VEGFR-1 Inhibits Neovascularization and Vascular Permeability
N. Patel
,
Li Sun
,
+13 authors
A. Howlett
Journal of Pharmacology and Experimental…
2003
Corpus ID: 30860003
Vascular endothelial growth factor (VEGF) is a key driver of the neovascularization and vascular permeability that leads to the…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
,
Terms of Service
, and
Dataset License
ACCEPT & CONTINUE